PARSIPPANY, N.J., July 18, 2012 – PDI, Inc. (Nasdaq: PDII) today announced that the client related to a previously disclosed contract has received FDA approval to market its product. PDI had entered ...

SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII), a pioneer in providing contract sales and commercial services to the biopharmaceutical industry, today announced the appointment of ...

PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as ...

PDI, Inc. (PDII) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion, Nancy Lurker, Chief Executive Officer of PDI, Inc. (PDII), will preside over the NASDAQ ...

ORANGEBURG, N.Y., July 2, 2014 /PRNewswire/ -- Professional Disposables International, Inc., (PDI) announced the appointment of Peter Cempellin and Patrick Treacy to senior leadership roles that drive ...

PDI to Focus on Growing Molecular Diagnostics Business; Plans to Change Name to Interpace Diagnostics Group PDI intends to utilize proceeds from the transaction to strengthen its balance sheet and ...

As Parsippany-based health care commercialization company PDI Inc. transitions into a molecular diagnostics firm, it is making changes in its executive leadership, it announced Tuesday.First, Nancy ...

Parsippany-based health care services company PDI, Inc., announced Tuesday that Graham G. Miao was named executive vice president and chief financial officer.When he starts in this role Monday, Oct.

“With PD One, pharmaceutical marketers have a new tool that bridges the gap between the direct sales model and digital marketing, creating an entirely new communication channel to more effectively ...

NEW YORK--(BUSINESS WIRE)--Prolias Technologies, Inc. has filed suit against PDI Inc. (NASDAQ: PDII), a New Jersey-based company. PDI Inc. is alleged to have engaged breach of contract, breach of ...

Please provide your email address to receive an email when new articles are posted on . Continuing its path in commercializing molecular diagnostic tests, PDI, Inc. announced its Interpace Diagnostics ...

PARSIPPANY -- Speaking to more than 30 members of the Executive Women of New Jersey (EWNJ) on June 4, Nancy Lurker, CEO of Parsippany-based, PDI Inc. (NASDAQ: PDII), shared personal experiences and ...